Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
LYEL | Lyell Immunopharma, Inc. | President and CEO, Director | $712K | +$21.4K | +3.09% | Aug 20, 2025 |
BPMC | Blueprint Medicines Corp | Director | $0 | Jul 17, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|